Alias: Femara
Zuiverheid: 99%min
CAS-registratienummer: 112809-51-5
Moleculaire formule: C17H11N5
Moleculair gewicht: 285.3
Cijfer: Farmaceutische kwaliteit
Gebruik: farmaceutisch materiaal
Femara, sold under the brand name Femara, is a prescription drug used to treat breast cancer in its advanced stages, and in women who have finished menopause. Doctors may use Femara off-label in fertility treatments to help encourage egg release (ovulation) in women. Femara belongs to a class of cancer drugs known as aromatase inhibitors, which work by preventing the body from converting a hormone called androgen into estrogen.
Letrozole is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer.
For pre-contest bodybuilders, Letrozole is almost a necessity to eliminate water retention and achieve the ripped look necessary to compete in today’s bodybuilding world.
| TESTITEMS |
SPECIFICATIE
|
RESULTATEN
|
|
Beschrijving
|
Wit kristallijn poeder
|
Wit poeder
|
|
Identificatie
|
Positief
|
Positief
|
|
Analyse(door HPLC)
|
98.0~102,0%
|
99.58%
|
|
Absorptie(E1cm)
|
465~495
|
486.5
|
|
Smeltpunt
|
191~195ºC
|
192.5~195.0ºC
|
|
Verlies bij drogen
|
0.5%maximaal
|
0.22%
|
|
Specifieke rotatie
|
+288º~ +298º
|
+295.2ºC
|
|
Residu bij ontsteking
|
0.1%maximaal
|
0.02%
|
|
Gerelateerde stoffen
|
Totaal:1.5%maximaal
|
<1.2%
|
|
|
Enkel:0.5%maximaal
|
<0.6%
|
|
Resterende oplosmiddelen
|
0.2%maximaal
|
0.1%
|
|
Zware metalen
|
20PPm max
|
<10PPm
|
